Analyst consensus rating
Replimune Group Analyst Rating: none
Direct answer
Replimune Group's consensus rating is none.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $19.50.
Forecast evidence checked October 17, 2026.
Get free Replimune Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $10.86
- Average price target
- $19.50
- High price target
- $24.00
- Low price target
- $14.00
- Low target gap
- +28.9%
- Target upside
- +79.6%
- High target gap
- +121%
- Target range width
- 92.1%
- Consensus rating
- none
- Analysts
- 6
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Replimune Group?
Replimune Group has a verified none consensus. The same dataset has an average price target of $19.50.
How far are Replimune Group's low and high targets from the recorded price?
The low target implies +28.9%, while the high target implies +121%.
How many analysts are included in Replimune Group's consensus?
The verified consensus includes 6 analysts.
How is Replimune Group's target upside or downside calculated?
The average target of $19.50 is divided by the recorded price of $10.86, then one is subtracted to produce +79.6%. This does not guarantee a future return.
When was Replimune Group's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.